Naveenkumar Singh is part of the Downstream Process Development Group at Ambrx Biopharma, Inc. and develops phase-appropriate purification processes for pre-clinical and clinical production. He has 10+ years of combined downstream process development experience in academic and industry settings. He received his Ph.D. in Biochemical Engineering (2016) from Jacobs University Bremen (Bremen, Germany), M.Sc. in Biotechnology (2009) from Jaipur National University (Jaipur, India), and B.Sc. in Biotechnology (2007) from the University of Pune (Pune, India).